Press release
Neurological Biomarker Market Is At A CAGR Of 15.4% During 2022-2032 | Abbott, Thermo Fisher Scientific, Bio-rad Laboratories, Merck
The global Neurological Biomarkers Market was valued at USD 6.8 Billion in 2022 and it is anticipated to grow up to USD 28.6 Billion by 2032, at a CAGR of 15.4% during the forecast period.Neurological Biomarkers is used to protect against the intentional interference of electronic signals. This equipment can be used to protect against radio frequency interference (RFI), electromagnetic interference (EMI), or other types of signal interference. There are a variety of anti-jamming technologies that can be used, depending on the type of interference that is being protected against. For example, RFI jamming can be countered with frequency-hopping spread spectrum (FHSS) technology, while EMI jamming can be countered with pulse-code modulation (PCM) or other digital modulation techniques.
Request free sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS10522
Market Trends and Drivers
Recent advancements in biomarkers, such as biomarker signatures are making neurological diseases more treatable. This has resulted in noninvasive testing, faster drug development, and early diagnosis. Furthermore, digital biomarkers provide various pharmaceutical companies with contextual and supplemental information to conclude clinical trial decisions. National Institute of Neurological Disorders and Stroke provides funding, such as development grants & cooperative agreements, for researchers conducting studies related to biomarker discovery, analytical validation, & clinical validation.
Major Players in the Global Catamaran Market
The key players in the Neurological Biomarkers Market are Abbott; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc.; Merck & Co., Inc.; Johnson & Johnson Services, Inc.; BANYAN BIOMARKERS, INC.; Myriad Genetics, Inc.; DiaGenic ASA; and Quanterixamong others.
COVID-19 Impact
The COVID-19 outbreak has had a significant impact on the market. As employment closures have curtailed import and export activities and closures of diagnostics centers and hospitals. For instance, according to an article titled "Impact of the COVID-19 pandemic on the surveillance, prevention, and control of antimicrobial resistance: a global survey" published in September 2021, there was a reduction in the availability of the nursing, medical, and public health staff for antimicrobial resistance by 71%, 69%, and 64%, respectively. However, with the release COVID-19 restrictions and resumed diagnosis and testing services in industries the studied market is expected to grow over the forecast period. Certain factors propelling the market growth are the rising burden of infectious diseases, technological advancements in microbial identification, increasing food safety concerns, and government initiatives and funding for promoting microbial identification.
Speak to Analyst for more details: https://www.globalinsightservices.com/request-customization/GIS10522
Global Neurological Biomarkers Market Segmentation
By Type
Genomic
Proteomic
Metabolomic
Imaging
Others
By Application
Alzheimer's Disease
Parkinson's Disease
Multiple Sclerosis
Autism Spectrum Disorder
Others
By End-user
Hospital & Hospital Laboratories
Independent Clinical Diagnostic Centers
Research Organizations
Others
Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS10522
With Global Insight Services, you receive:
10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurological Biomarker Market Is At A CAGR Of 15.4% During 2022-2032 | Abbott, Thermo Fisher Scientific, Bio-rad Laboratories, Merck here
News-ID: 3290214 • Views: …
More Releases from Global Insight Services
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved…
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the…
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview
Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger…
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview
Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire…
More Releases for Neurological
Major Growth Driver Identified in 2025 Neurological Biomarkers Market: Rising Pr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Neurological Biomarkers Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of neurological biomarkers has seen a swift augmentation in the past few years. Projected to escalate from $10.7 billion in 2024 to $11.96 billion in 2025, it holds a compound annual growth…
Neurological Biomarkers Market : An Overview
Introduction:
Neurological biomarkers are biological markers that provide insight into the physiological, pathological, and pharmacological responses of the nervous system. These biomarkers play a critical role in diagnosing, monitoring, and treating neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy. With growing advancements in genomics, proteomics, and molecular biology, neurological biomarkers have emerged as essential tools in precision medicine, allowing for early detection and personalized treatment plans for…
Neurological Biomarkers Market: An Overview
Introduction:
Neurological biomarkers refer to measurable indicators that can be used to detect or monitor neurological diseases or disorders. These biomarkers provide critical insights into the diagnosis, progression, and treatment of neurological conditions such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and traumatic brain injury. Neurological biomarkers are typically measured in bodily fluids like cerebrospinal fluid (CSF), blood, or even imaging techniques like MRI. With advancements in molecular biology, genomics, and…
Nurturing Neurological Wellness: Insights into the Global Neurological Disorder …
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧:
Neurological disorders represent a significant healthcare challenge, affecting millions worldwide and encompassing a diverse spectrum of conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and multiple sclerosis, among others. In the quest for effective management and treatment, pharmaceutical interventions play a pivotal role. As we embark on a journey to explore the global neurological disorder drugs market, we unravel the complex interplay of resin types, applications, technologies, end-use industries, and…
Neurological Biomarkers Market - Decoding Brain Health: Biomarkers Revolutionizi …
Newark, New Castle, USA: The "Neurological Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Neurological Biomarkers Market: https://www.growthplusreports.com/report/neurological-biomarkers-market/8040
This latest report researches the industry structure, sales, revenue,…
Neurological Disorder Drugs Market - Advancing Neurological Health through Innov …
Newark, New Castle, USA - new report, titled Neurological Disorder Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Neurological Disorder Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Neurological Disorder Drugs market. The report offers an overview of…
